EVALUATION OF LISA-TRACKER IMMUNOASSAY INFLIXIMAB AND ANTI-INFLIXIMAB FOR THE THERAPEUTIC DRUG MONITORING OF SB2.

Anne-Emmanuelle Berger  1     Alice Haccourt  1     Joseph Salameh  2     Xavier Roblin  3     Stéphane Paul  4    
1 CHU Saint-Etienne,Laboratoire d'Immunologie CIC1408,Saint-Etienne,France
2 Biogen France,Nanterre,France
3 University of St. Etienne Dept. de Gastroenterologie,Saint Etienne,France
4 Hôpital Nord,Immunology,Saint Etienne,France

Conference
25th UEG Week 2017

Citation
United European Gastroenterology Journal 2017; 5 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing